後天性感染症検査の世界市場 2020年

• 英文タイトル：Global Acquired Infections Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113478 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：機械・機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、後天性感染症検査の世界市場を調査対象にし、後天性感染症検査の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（疾病検査、薬剤耐性検査）、用途別分析（病院、クリニック、外来手術センター（ASC）、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Gen-Probe、Becton Dickinson、Cephei、Siemens AG、Qiagen GmbH、Alere、bioMerieux、Abbott Laboratories、Roche、Meridian Bioscience, Inc. ・企業別売上、市場シェア ・後天性感染症検査の地域別市場分析 ・後天性感染症検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・後天性感染症検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・後天性感染症検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・後天性感染症検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・後天性感染症検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・後天性感染症検査の種類別市場規模2015-2020：疾病検査、薬剤耐性検査 ・後天性感染症検査の用途別市場規模2015-2020：病院、クリニック、外来手術センター（ASC）、その他 ・後天性感染症検査の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Acquired Infections Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Acquired Infections Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Acquired Infections Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acquired Infections Testing market has been segmented into:
Disease Testing
Drug-Resistance Testing

By Application, Acquired Infections Testing has been segmented into:
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acquired Infections Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Acquired Infections Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acquired Infections Testing market.

The report offers in-depth assessment of the growth and other aspects of the Acquired Infections Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acquired Infections Testing Market Share Analysis
Acquired Infections Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acquired Infections Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acquired Infections Testing sales, revenue and market share for each player covered in this report.

The major players covered in Acquired Infections Testing are:
Gen-Probe
Becton Dickinson
Cephei
Siemens AG
Qiagen GmbH
Alere
bioMerieux
Abbott Laboratories
Roche
Meridian Bioscience, Inc.

レポート目次

---

1 Acquired Infections Testing Market Overview
1.1 Product Overview and Scope of Acquired Infections Testing
1.2 Classification of Acquired Infections Testing by Type
1.2.1 Global Acquired Infections Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acquired Infections Testing Revenue Market Share by Type in 2019
1.2.3 Disease Testing
1.2.4 Drug-Resistance Testing
1.3 Global Acquired Infections Testing Market by Application
1.3.1 Overview: Global Acquired Infections Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Global Acquired Infections Testing Market by Regions
1.4.1 Global Acquired Infections Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acquired Infections Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acquired Infections Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acquired Infections Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acquired Infections Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acquired Infections Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acquired Infections Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Gen-Probe
2.1.1 Gen-Probe Details
2.1.2 Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gen-Probe SWOT Analysis
2.1.4 Gen-Probe Product and Services
2.1.5 Gen-Probe Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Becton Dickinson
2.2.1 Becton Dickinson Details
2.2.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Becton Dickinson SWOT Analysis
2.2.4 Becton Dickinson Product and Services
2.2.5 Becton Dickinson Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cephei
2.3.1 Cephei Details
2.3.2 Cephei Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cephei SWOT Analysis
2.3.4 Cephei Product and Services
2.3.5 Cephei Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens AG
2.4.1 Siemens AG Details
2.4.2 Siemens AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens AG SWOT Analysis
2.4.4 Siemens AG Product and Services
2.4.5 Siemens AG Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Qiagen GmbH
2.5.1 Qiagen GmbH Details
2.5.2 Qiagen GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen GmbH SWOT Analysis
2.5.4 Qiagen GmbH Product and Services
2.5.5 Qiagen GmbH Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Alere
2.6.1 Alere Details
2.6.2 Alere Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Alere SWOT Analysis
2.6.4 Alere Product and Services
2.6.5 Alere Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 bioMerieux
2.7.1 bioMerieux Details
2.7.2 bioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 bioMerieux SWOT Analysis
2.7.4 bioMerieux Product and Services
2.7.5 bioMerieux Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott Laboratories SWOT Analysis
2.8.4 Abbott Laboratories Product and Services
2.8.5 Abbott Laboratories Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Meridian Bioscience, Inc.
2.10.1 Meridian Bioscience, Inc. Details
2.10.2 Meridian Bioscience, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Meridian Bioscience, Inc. SWOT Analysis
2.10.4 Meridian Bioscience, Inc. Product and Services
2.10.5 Meridian Bioscience, Inc. Acquired Infections Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acquired Infections Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acquired Infections Testing Players Market Share
3.2.2 Top 10 Acquired Infections Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acquired Infections Testing Revenue and Market Share by Regions
4.2 North America Acquired Infections Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Acquired Infections Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acquired Infections Testing Revenue and Growth Rate (2015-2020)
4.5 South America Acquired Infections Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acquired Infections Testing Revenue and Growth Rate (2015-2020)
5 North America Acquired Infections Testing Revenue by Countries
5.1 North America Acquired Infections Testing Revenue by Countries (2015-2020)
5.2 USA Acquired Infections Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Acquired Infections Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Acquired Infections Testing Revenue and Growth Rate (2015-2020)
6 Europe Acquired Infections Testing Revenue by Countries
6.1 Europe Acquired Infections Testing Revenue by Countries (2015-2020)
6.2 Germany Acquired Infections Testing Revenue and Growth Rate (2015-2020)
6.3 UK Acquired Infections Testing Revenue and Growth Rate (2015-2020)
6.4 France Acquired Infections Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Acquired Infections Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acquired Infections Testing Revenue by Countries
7.1 Asia-Pacific Acquired Infections Testing Revenue by Countries (2015-2020)
7.2 China Acquired Infections Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Acquired Infections Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Acquired Infections Testing Revenue and Growth Rate (2015-2020)
7.5 India Acquired Infections Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
8 South America Acquired Infections Testing Revenue by Countries
8.1 South America Acquired Infections Testing Revenue by Countries (2015-2020)
8.2 Brazil Acquired Infections Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Acquired Infections Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acquired Infections Testing by Countries
9.1 Middle East & Africa Acquired Infections Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Acquired Infections Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Acquired Infections Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Acquired Infections Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acquired Infections Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Acquired Infections Testing Market Forecast by Type (2019-2024)
10.3 Disease Testing Revenue Growth Rate (2015-2025)
10.4 Drug-Resistance Testing Revenue Growth Rate (2015-2025)
11 Global Acquired Infections Testing Market Segment by Application
11.1 Global Acquired Infections Testing Revenue Market Share by Application (2015-2020)
11.2 Acquired Infections Testing Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centers (ASC) Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Acquired Infections Testing Market Size Forecast (2021-2025)
12.1 Global Acquired Infections Testing Market Size Forecast (2021-2025)
12.2 Global Acquired Infections Testing Market Forecast by Regions (2021-2025)
12.3 North America Acquired Infections Testing Revenue Market Forecast (2021-2025)
12.4 Europe Acquired Infections Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acquired Infections Testing Revenue Market Forecast (2021-2025)
12.6 South America Acquired Infections Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acquired Infections Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Acquired Infections Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acquired Infections Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acquired Infections Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acquired Infections Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Gen-Probe Corporate Information, Location and Competitors
Table 6. Gen-Probe Acquired Infections Testing Major Business
Table 7. Gen-Probe Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 8. Gen-Probe SWOT Analysis
Table 9. Gen-Probe Acquired Infections Testing Product and Solutions
Table 10. Gen-Probe Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Becton Dickinson Corporate Information, Location and Competitors
Table 12. Becton Dickinson Acquired Infections Testing Major Business
Table 13. Becton Dickinson Acquired Infections Testing Total Revenue (USD Million) (2018-2019)
Table 14. Becton Dickinson SWOT Analysis
Table 15. Becton Dickinson Acquired Infections Testing Product and Solutions
Table 16. Becton Dickinson Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cephei Corporate Information, Location and Competitors
Table 18. Cephei Acquired Infections Testing Major Business
Table 19. Cephei Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 20. Cephei SWOT Analysis
Table 21. Cephei Acquired Infections Testing Product and Solutions
Table 22. Cephei Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Siemens AG Corporate Information, Location and Competitors
Table 24. Siemens AG Acquired Infections Testing Major Business
Table 25. Siemens AG Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 26. Siemens AG SWOT Analysis
Table 27. Siemens AG Acquired Infections Testing Product and Solutions
Table 28. Siemens AG Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Qiagen GmbH Corporate Information, Location and Competitors
Table 30. Qiagen GmbH Acquired Infections Testing Major Business
Table 31. Qiagen GmbH Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 32. Qiagen GmbH SWOT Analysis
Table 33. Qiagen GmbH Acquired Infections Testing Product and Solutions
Table 34. Qiagen GmbH Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Alere Corporate Information, Location and Competitors
Table 36. Alere Acquired Infections Testing Major Business
Table 37. Alere Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 38. Alere SWOT Analysis
Table 39. Alere Acquired Infections Testing Product and Solutions
Table 40. Alere Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. bioMerieux Corporate Information, Location and Competitors
Table 42. bioMerieux Acquired Infections Testing Major Business
Table 43. bioMerieux Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 44. bioMerieux SWOT Analysis
Table 45. bioMerieux Acquired Infections Testing Product and Solutions
Table 46. bioMerieux Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abbott Laboratories Corporate Information, Location and Competitors
Table 48. Abbott Laboratories Acquired Infections Testing Major Business
Table 49. Abbott Laboratories Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 50. Abbott Laboratories SWOT Analysis
Table 51. Abbott Laboratories Acquired Infections Testing Product and Solutions
Table 52. Abbott Laboratories Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Acquired Infections Testing Major Business
Table 55. Roche Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Acquired Infections Testing Product and Solutions
Table 58. Roche Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Meridian Bioscience, Inc. Corporate Information, Location and Competitors
Table 60. Meridian Bioscience, Inc. Acquired Infections Testing Major Business
Table 61. Meridian Bioscience, Inc. Acquired Infections Testing Total Revenue (USD Million) (2017-2018)
Table 62. Meridian Bioscience, Inc. SWOT Analysis
Table 63. Meridian Bioscience, Inc. Acquired Infections Testing Product and Solutions
Table 64. Meridian Bioscience, Inc. Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Acquired Infections Testing Revenue (Million USD) by Players (2015-2020)
Table 66. Global Acquired Infections Testing Revenue Share by Players (2015-2020)
Table 67. Global Acquired Infections Testing Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Acquired Infections Testing Revenue Market Share by Regions (2015-2020)
Table 69. North America Acquired Infections Testing Revenue by Countries (2015-2020)
Table 70. North America Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Table 71. Europe Acquired Infections Testing Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Acquired Infections Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Acquired Infections Testing Revenue by Countries (2015-2020)
Table 74. South America Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Acquired Infections Testing Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Table 77. Global Acquired Infections Testing Revenue (Million USD) by Type (2015-2020)
Table 78. Global Acquired Infections Testing Revenue Share by Type (2015-2020)
Table 79. Global Acquired Infections Testing Revenue Forecast by Type (2021-2025)
Table 80. Global Acquired Infections Testing Revenue by Application (2015-2020)
Table 81. Global Acquired Infections Testing Revenue Share by Application (2015-2020)
Table 82. Global Acquired Infections Testing Revenue Forecast by Application (2021-2025)
Table 83. Global Acquired Infections Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acquired Infections Testing Picture
Figure 2. Global Acquired Infections Testing Revenue Market Share by Type in 2019
Figure 3. Disease Testing Picture
Figure 4. Drug-Resistance Testing Picture
Figure 5. Acquired Infections Testing Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgery Centers (ASC) Picture
Figure 9. Others Picture
Figure 10. Global Acquired Infections Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Acquired Infections Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acquired Infections Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Acquired Infections Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Acquired Infections Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Acquired Infections Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Acquired Infections Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Acquired Infections Testing Revenue Market Share by Regions in 2018
Figure 24. North America Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Acquired Infections Testing Revenue Market Share by Countries in 2019
Figure 31. USA Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Acquired Infections Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Acquired Infections Testing Revenue Market Share by Countries in 2019
Figure 43. China Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Acquired Infections Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Acquired Infections Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Acquired Infections Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Acquired Infections Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Acquired Infections Testing Revenue Share by Type (2015-2020)
Figure 59. Global Acquired Infections Testing Revenue Share by Type in 2019
Figure 60. Global Acquired Infections Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global Disease Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Drug-Resistance Testing Revenue Growth Rate (2015-2020)
Figure 63. Global Acquired Infections Testing Revenue Share by Application (2015-2020)
Figure 64. Global Acquired Infections Testing Revenue Share by Application in 2019
Figure 65. Global Acquired Infections Testing Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgery Centers (ASC) Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Acquired Infections Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Acquired Infections Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Acquired Infections Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Acquired Infections Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Acquired Infections Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Acquired Infections Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Acquired Infections Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Acquired Infections Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---